STVN - CIK 0001849853
Stevanato Group S.p.A. trades as STVN and has a market capitalization of $5.21 B, making it the #1358 largest US-listed company by market value. This page tracks Stevanato Group S.p.A. through 188 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| 6-K | - | 2026-05-15 |
| SCHEDULE 13G | - | 2026-05-15 |
| 6-K | - | 2026-05-11 |
| 6-K | - | 2026-05-07 |
| 6-K | - | 2026-05-07 |
| 6-K | - | 2026-05-07 |
| New insider ownership | 3 | 2026-03-25 |
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026
Pre-registration: Participants who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. We encourage participants to pre-register for the conference call using the following link: STVN conference call pre-registration.
Stevanato Group to Participate in Three Upcoming Investor Conferences
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins
The largest companies sharing Stevanato Group S.p.A.'s SEC industry classification (surgical & medical instruments & apparatus).
Stevanato Group S.p.A. (STVN) has a market capitalization of $5.21 B as of 2026-06-10, ranking #1358 among US-listed companies.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.